Login / Signup

Exploring heterogeneous expression of beta-actin (ACTB) in bladder cancer by producing a monoclonal antibody 6D6.

Mohammadrasul ZareinejadZahra FaghihAmin RamezaniAkbar SafaeiAbbas Ghaderi
Published in: BMC urology (2024)
The heterogeneous expression of ACTB may suggest the potential value of this marker in the diagnosis or prognosis of cancer.
Keyphrases
  • monoclonal antibody
  • poor prognosis
  • papillary thyroid
  • binding protein
  • squamous cell carcinoma
  • risk assessment
  • human health
  • young adults
  • climate change
  • cell migration